EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Genetic Cascade Screening for Familial Hypercholesterolemia

David Nanchen, Aziz Chaouch, Renzo Scuderi, Vincent Faivre, Thomas von Känel, Georg Ehret, Nathalie Brun, Isabella Sudano, Hans Rickli, Grégoire Girod, Audrey Butty Dettwiler, Kristina Krasieva und 8 weitere

JAMA Network Open · 13.04.2026 · 9 (4) · e266100

DOI: 10.1001/jamanetworkopen.2026.6100 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 13.04.2026. Verfasst von David Nanchen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Genetic Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Familial hypercholesterolemia is a common genetic disorder associated with premature cardiovascular disease. Genetic cascade screening is recommended but remains underused due to privacy laws that prevent clinicians from directly contacting at-risk relatives.

Objective

To examine whether implementing a web-based communication platform in a patient-mediated genetic cascade screening program for familial hypercholesterolemia increases uptake compared with usual care. Design, Setting, and Participants This open-label, multicenter, implementation randomized clinical trial (CATCH) was conducted between November 1, 2020, and October 31, 2023, at 7 cardiovascular prevention or lipid clinics across Switzerland, representing French-, German-, and Italian-speaking regions. Adults aged 16 years or older with genetically confirmed familial hypercholesterolemia and at least 1 eligible first-degree relative living in Switzerland participated. A total of 87 index patients with 359 eligible first-degree relatives were randomized by family cluster (1:1) to the intervention or usual care arm.

Intervention

A secure web-based platform allowing participants to send preprepared electronic messages (email or text) to their relatives, linking them directly to participating centers for genetic testing. Main Outcomes and Measures The primary outcome was cascade screening uptake, defined as the proportion of eligible first-degree relatives undergoing genetic testing within 6 months. The secondary outcome was new cases identified.

Results

Among 221 adults screened across multiple families, 87 (39.4%) had genetically confirmed familia hypercholesterolemia (median [IQR] age, 49.2 [16.4-83.7] years; 46 [52.9%] female; median [IQR] highest low-density lipoprotein cholesterol, 289.58 [139.00-498.07] mg/dL); 43 were randomized to the usual care arm, and 44 were randomized to the intervention arm. Among the 359 eligible relatives (median family size, 4), 99 (27.6%) underwent genetic testing. Uptake was higher in the intervention arm (30.4%; 95% CI, 22.0%-40.4%) than in usual care arm (16.7%; 95% CI, 10.1%-26.3%), yielding an odds ratio of 2.18 (95% CI, 1.06-4.51; P = .03). New case identification was also greater (17.0% vs 8.1%; odds ratio, 2.32; 95% CI, 1.07-5.05; P = .03). Newly identified patients were often untreated or had modifiable risk factors. Conclusions and Relevance In this randomized clinical trial of patient-mediated genetic cascade screening supported by a web-based platform, participation in genetic testing and detection of familial hypercholesterolemia was increased compared with usual care. These results suggest that the use of digital communication tools enhanced the reach and effectiveness of genetic screening programs within privacy-regulated health systems. Trial Registration ClinicalTrials.gov Identifier: NCT04419090

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIGenetic TestingHumansFemaleMaleMiddle AgedAdultSwitzerlandAged

Autor:innen und Institutionen

  • Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
  • Central Institute of the Hospitals, Hôpital du Valais, Sion, Switzerland.
  • Division of Cardiology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
  • Children Clinic, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
  • Department of Cardiology, University Heart Center, Zurich University Hospital, University of Zurich, Zurich, Switzerland.
  • Department of Cardiology, Kantonsspital St Gallen, St Gallen, Switzerland.

Zitieren

APA

Nanchen, D., Chaouch, A., Scuderi, R., Faivre, V., von Känel, T., Ehret, G., Brun, N., Sudano, I., Rickli, H., Girod, G., Dettwiler, A. B., Krasieva, K., Podmore, C., Rodondi, N., Moutzouri, E., Ballhausen, D., Del Giorno, R., von Eckardstein, A., Beer, J. H., & Gallino, A. (2026). Genetic Cascade Screening for Familial Hypercholesterolemia. JAMA Network Open, 9(4), e266100. https://doi.org/10.1001/jamanetworkopen.2026.6100

Vancouver

Nanchen D, Chaouch A, Scuderi R, Faivre V, von Känel T, Ehret G, et al. Genetic Cascade Screening for Familial Hypercholesterolemia. JAMA Network Open. 2026;9(4):e266100. doi:10.1001/jamanetworkopen.2026.6100

BibTeX
@article{Nanchen2026,
  author = {Nanchen, David and Chaouch, Aziz and Scuderi, Renzo and Faivre, Vincent and von Känel, Thomas and Ehret, Georg and Brun, Nathalie and Sudano, Isabella and Rickli, Hans and Girod, Grégoire and Dettwiler, Audrey Butty and Krasieva, Kristina and Podmore, Clara and Rodondi, Nicolas and Moutzouri, Elisavet and Ballhausen, Diana and Del Giorno, Rosaria and von Eckardstein, Arnold and Beer, Jürg H and Gallino, Augusto},
  title = {Genetic Cascade Screening for Familial Hypercholesterolemia},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {4},
  pages = {e266100},
  doi = {10.1001/jamanetworkopen.2026.6100}
}
Kostenlos starten →